In the small first-in-human study, AB-1002 showed an encouraging safety profile and early signs of efficacy, investigators ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible resultsSome results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback